Diagnostic and testing
Importance of biomarkers in the ulcerative colitis market
There is a lack of reliable biomarkers that are indicative of outcomes and disease severity for UC patients.
Application to screen newborns for adrenoleukodystrophy in the UK is denied
Severe RSV infections pose threat to millions of at-risk infants this fall
Concerns over safety on fertility are unfounded for Covid-19 vaccines
Entrance of novel therapies will drive Pompe disease market growth
PerkinElmer agrees to acquire antibody maker BioLegend for $5.25bn
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
